Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

The combination therapy was effective and well-tolerated, especially in young patients.

Tiny particles called anionic squarticles can effectively remove a common antidepressant from the body after an overdose.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning, especially for skin and hair symptoms.

MK-5108 is safe and shows potential against tumors, especially alone.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A woman poisoned with thallium was successfully treated with activated charcoal and Prussian blue.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Overexpressing SSAT enzyme reduces prostate tumor growth in mice.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

The treatment was not recommended due to limited effectiveness and significant side effects.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.